AR106493A1 - Uso terapéutico de una solución oftálmica acuosa estéril - Google Patents
Uso terapéutico de una solución oftálmica acuosa estérilInfo
- Publication number
- AR106493A1 AR106493A1 ARP160103301A ARP160103301A AR106493A1 AR 106493 A1 AR106493 A1 AR 106493A1 AR P160103301 A ARP160103301 A AR P160103301A AR P160103301 A ARP160103301 A AR P160103301A AR 106493 A1 AR106493 A1 AR 106493A1
- Authority
- AR
- Argentina
- Prior art keywords
- ophthalmic solution
- therapeutic use
- solution
- acetylcysteinyl
- chitosan
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Solución oftálmica acuosa estéril que comprende N-(N-acetilcisteinil)quitosano o una de sus sales farmacéuticamente aceptables en una solución portadora, en donde el N-(N-acetilcisteinil)quitosano tiene un contenido de grupos tiol libres en una cantidad de 80 mmol/g de polímero a 280 mmol/g de polímero, para el uso específico en la prevención o el tratamiento del síndrome del ojo seco o signos y/o síntomas de ojo seco, en donde dicha solución se aplica antes de irse a dormir.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15192361 | 2015-10-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR106493A1 true AR106493A1 (es) | 2018-01-17 |
Family
ID=54476730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160103301A AR106493A1 (es) | 2015-10-30 | 2016-10-28 | Uso terapéutico de una solución oftálmica acuosa estéril |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10813943B2 (es) |
| EP (1) | EP3368006B1 (es) |
| JP (1) | JP2018532753A (es) |
| KR (1) | KR20180066240A (es) |
| CN (1) | CN108348457A (es) |
| AR (1) | AR106493A1 (es) |
| BR (1) | BR112018008650A2 (es) |
| CA (1) | CA3003535A1 (es) |
| ES (1) | ES2773537T3 (es) |
| IL (1) | IL259049A (es) |
| MX (1) | MX2018005453A (es) |
| PL (1) | PL3368006T3 (es) |
| RU (1) | RU2018119674A (es) |
| WO (1) | WO2017072235A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018202783A1 (en) | 2017-05-03 | 2018-11-08 | Croma-Pharma Gmbh | Sterile aqueous ophthalmic solution containing n-(n-acetylcysteinyl)-chitosan for treating non-infectious corneal disorders |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE431258B (sv) | 1982-07-02 | 1984-01-23 | Tiru Maj Britt Ingegerd | Komposition med reglerad forendring av opalescens eller uppklarning vid valda temperaturer och sett for dess framstellning samt anvendning av kompositionen |
| IT1258781B (it) | 1992-01-16 | 1996-02-29 | Zambon Spa | Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol |
| FR2692582B1 (fr) | 1992-06-18 | 1998-09-18 | Flamel Tech Sa | Nouveaux derives reticulables de collagene, leur procede d'obtention et leur application a la preparation de biomateriaux. |
| AT406054B (de) | 1998-11-04 | 2000-02-25 | Andreas Bernkop-Schnuerch | Verfahren zur verbesserung der mucoadhäsion von polymeren sowie deren herstellung und verwendung |
| WO2006087968A1 (ja) * | 2005-02-17 | 2006-08-24 | Senju Pharmaceutical Co, . Ltd. | 眼科用固形外用薬剤 |
| PT2107913E (pt) | 2006-12-22 | 2012-05-10 | Croma Pharma Ges M B H | Uso de polissacarídeos tiolados para aumento de tecidos |
| BRPI0807065A2 (pt) | 2007-01-31 | 2017-03-21 | Allergan Inc | biomateriais novos para liberação de fármaco ocular e um método para fazer e usar os mesmos |
| US9452592B2 (en) | 2007-08-28 | 2016-09-27 | Cryovac, Inc. | Multilayer film having an active oxygen barrier layer with radiation enhanced active barrier properties |
| US9433636B2 (en) | 2008-04-24 | 2016-09-06 | Medtronic, Inc. | Protective gel based on chitosan and oxidized polysaccharide |
| US8530632B2 (en) | 2008-04-24 | 2013-09-10 | Medtronic Xomed, Inc. | Chitosan-containing protective composition |
| AU2009240511B2 (en) | 2008-04-24 | 2015-01-22 | Medtronic, Inc. | Thiolated chitosan gel |
| US9439925B2 (en) * | 2010-04-06 | 2016-09-13 | Synedgen, Inc. | Methods and compositions for treating wounds utilizing chitosan compounds |
| AU2015257874B2 (en) | 2014-05-07 | 2019-11-28 | Croma-Pharma Gesellschaft M.B.H. | Aqueous ophthalmic solution and method for treating dry eye syndrome |
-
2016
- 2016-10-27 KR KR1020187014437A patent/KR20180066240A/ko unknown
- 2016-10-27 WO PCT/EP2016/075938 patent/WO2017072235A1/en active Application Filing
- 2016-10-27 EP EP16787868.5A patent/EP3368006B1/en active Active
- 2016-10-27 MX MX2018005453A patent/MX2018005453A/es unknown
- 2016-10-27 PL PL16787868T patent/PL3368006T3/pl unknown
- 2016-10-27 BR BR112018008650-9A patent/BR112018008650A2/pt not_active Application Discontinuation
- 2016-10-27 US US15/769,477 patent/US10813943B2/en active Active
- 2016-10-27 CA CA3003535A patent/CA3003535A1/en not_active Abandoned
- 2016-10-27 ES ES16787868T patent/ES2773537T3/es active Active
- 2016-10-27 CN CN201680063924.3A patent/CN108348457A/zh active Pending
- 2016-10-27 RU RU2018119674A patent/RU2018119674A/ru not_active Application Discontinuation
- 2016-10-27 JP JP2018522687A patent/JP2018532753A/ja not_active Withdrawn
- 2016-10-28 AR ARP160103301A patent/AR106493A1/es unknown
-
2018
- 2018-04-30 IL IL259049A patent/IL259049A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2773537T3 (es) | 2020-07-13 |
| RU2018119674A3 (es) | 2019-12-02 |
| MX2018005453A (es) | 2018-08-01 |
| RU2018119674A (ru) | 2019-12-02 |
| JP2018532753A (ja) | 2018-11-08 |
| IL259049A (en) | 2018-07-31 |
| EP3368006A1 (en) | 2018-09-05 |
| CN108348457A (zh) | 2018-07-31 |
| KR20180066240A (ko) | 2018-06-18 |
| PL3368006T3 (pl) | 2020-06-01 |
| BR112018008650A2 (pt) | 2018-10-30 |
| US10813943B2 (en) | 2020-10-27 |
| CA3003535A1 (en) | 2017-05-04 |
| US20180296589A1 (en) | 2018-10-18 |
| EP3368006B1 (en) | 2019-12-04 |
| WO2017072235A1 (en) | 2017-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2016002815A1 (es) | Solución oftálmica acuosa y método para tratar el síndrome del ojo seco | |
| CL2020000122A1 (es) | Métodos de tratamiento para la fibrosis quística. | |
| CL2016002812A1 (es) | Uso de ácido 3-2,3,5,6-tetrafluoro-3-trifluorometoxi-bifenil-4-ilcarbamoil-tiofeno-2-carboxílico para preparar un medicamento útil para tratar una enfermedad ocular que es uveítis, ojo seco o causada por un adenovirus composición formulación. | |
| CL2016000556A1 (es) | Nanopartículas poliméricas terapéuticas y métodos para su elaboración y uso. | |
| AR096478A1 (es) | Composiciones para el tratamiento de superficie que comprenden tintes fotocromáticos | |
| CR20160477A (es) | Nanopartículas terapéuticas que comprenden un agente terapéutico, y métodos para su elaboración y uso | |
| CR20130377A (es) | Métodos y productos de fármaco para tratar enfermedad de alzheimer | |
| BR102015017380A2 (pt) | dispositivo para a reticulação do tecido do olho, e, composição farmacêutica | |
| CL2016001756A1 (es) | Preparación farmacéutica que comprende 0,001-0,003 pv de 6-4-pirazol-1-ilbencilpiridin-3-ilsulfonilaminometilpiridin-2-ilaminoacetato de isopropilo o una sal del mismo uso para el tratamiento o prevención de glaucoma o hipertensión ocular. | |
| CY1124596T1 (el) | Φαρμακευτικη συνθεση τραμαδολης για οφθαλμικη χρηση | |
| ECSP11011076A (es) | Tratamiento de trastornos cognitivos con (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma | |
| CY1125033T1 (el) | Σκευασμα μεθοτρεξατης | |
| TR201901348T4 (tr) | Metap-2 inhibitörleri olarak pirolidinon türevleri. | |
| AR112144A1 (es) | Compuestos para el tratamiento del sarcoma | |
| CL2018003281A1 (es) | Análogo de trifluoroetil quinolina específico para usarse en el tratamiento del síndrome de fosfoinositida 3-cinasa delta activada (apds). | |
| EA201691860A1 (ru) | Пептидный медикамент в виде сухого порошка | |
| AR110404A1 (es) | MÉTODOS PARA EL TRATAMIENTO DE ENFERMEDADES FIBRÓTICAS UTILIZANDO EL INTERFERÓN-l | |
| AR103415A1 (es) | Tratamiento de pacientes pediátricos con diabetes mellitus de tipo 2 | |
| AR106057A1 (es) | Composición con efecto antiviral, composición farmacéutica | |
| CL2016001843A1 (es) | Uso de una composición que comprende a) un compuesto de fórmula (ia) definida o una sal del mismo y b) un portador o excipiente farmacéuticamente aceptable para preparar un medicamento útil para tratar una afección alérgica en un mamífero. | |
| BR112019004838A2 (pt) | tratamento de linfoma não-hodgkin usando lilotomab e 177lu-lilotomab satetraxetan | |
| AR106493A1 (es) | Uso terapéutico de una solución oftálmica acuosa estéril | |
| AR106494A1 (es) | Uso terapéutico de una solución oftálmica acuosa estéril, método de tratamiento | |
| TR201819920T4 (tr) | Kuru göz sendromunun tedavisinde kullanım için oftalmik bileşimler. | |
| TR201903234T4 (tr) | Parkinson hastalığının tedavisinde kullanılmaya yönelik dopamin içeren farmasötik çözelti. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |